Safety and immunogenicity of rSh28GST antigen in humans: phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis.
Treatment of urinary schistosomiasis by chemotherapy remains challenging due to rapid re-infection and possibly to limited susceptibility to praziquantel treatment. Therefore, therapeutic vaccines represent an attractive alternative control strategy. The objectives of this study were to assess the s...
Saved in:
Main Authors: | Gilles Riveau (Author), Dominique Deplanque (Author), Franck Remoué (Author), Anne-Marie Schacht (Author), Hubert Vodougnon (Author), Monique Capron (Author), Michel Thiry (Author), Joseph Martial (Author), Christian Libersa (Author), André Capron (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of the rSh28GST urinary schistosomiasis vaccine: A phase 3 randomized, controlled trial in Senegalese children.
by: Gilles Riveau, et al.
Published: (2018) -
Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
by: David J Diemert, et al.
Published: (2017) -
Correction: Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
by: David J Diemert, et al.
Published: (2020) -
Glutathione Transferase (GST)-Activated Prodrugs
by: Andrea Calderan, et al.
Published: (2013) -
When creativity wakes up emotions: an illustration of a creative course for pre-service teacher training
by: Aleksandra Vuichard, et al.
Published: (2024)